Elderly immune response to COVID-19 under the microscope
NCT ID NCT04563650
First seen Jun 20, 2026 · Last updated Jun 20, 2026
Summary
This study looks at how long COVID-19 neutralizing antibodies stay in the blood of elderly nursing home residents. Researchers will take blood samples from 98 participants to measure antibody levels over time. The goal is to understand how aging affects the immune response to COVID-19 and future vaccines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOSENESCENCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Amiens
Amiens, 80480, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help tailor COVID-19 vaccination strategies for older adults by revealing how their immune system responds.
What could go wrong
This is an observational study with no treatment being tested, so it won't directly lead to a new therapy. Results may not apply to all elderly populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.